Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine plus conventional chemotherapy in pediatric acute myeloid leukemia
ChiCTR1900023368Phase 4Recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-sen University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of decitabine in acute myeloid leukemia (AML), sponsored by The Seventh Affiliated Hospital, Sun Yat-sen University. Primary endpoint: DNA methylation status. Started Jan 2019; status: recruiting.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on ChiCTR1900023368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023368.